30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Amgen Fremont Inc (ABGX)

Track

Stock chart
Ticker: ABGX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
RINGO WILLIAM R
CEO and President
1 purchase — total 41,450 USD
Buy 28 Feb 2005
Value US$4,191,753.75 | Price 82.02 | Shares 54,116
Planned sale 29 Dec 2004
Value US$1,538,097.31 | Price 156.65 | Shares 93,602
Sale 26 Aug 2004
Value US$111,000.00 | Price 9.25 | Shares 12,000
Sale 14 Apr 2004
Value US$183,233.34 | Price 13.33 | Shares 13,748
Sale 14 Apr 2004
Value US$423,297.28 | Price 13.33 | Shares 31,760
Buy 6 Feb 2004
Value US$15,205.00 | Price 15.21 | Shares 1,000
Planned sale 6 Feb 2004
Value US$61,854.08 | Price 15.22 | Shares 4,064
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2005-03-02 2005-02-28 B Purchase RINGO WILLIAM R

CEO and President

Executive Director
54,116 +16.4%
82.02
US$4,191,754 		54,116 +16.4% 82.02 US$4,191,754
2005-01-03 2004-12-29 PlS Planned sale DAVIS C GEOFFREY

Chief Scientific Officer

Officer
93,602 +16.4%
156.65
US$1,538,097 		93,602 +16.4% 156.65 US$1,538,097
2004-08-30 2004-08-26 S Sale DAVIS C GEOFFREY

Chief Scientific Officer

Officer
25,182 +9.9%
85.69
US$4,549,506 		25,182 +9.9% 85.69 US$4,549,506
2004-04-16 2004-04-14 S Sale DAVIS C GEOFFREY

Chief Scientific Officer

Officer
13,748 -49.2%
13.33
US$183,233 		13,748 -49.2% 13.33 US$183,233
2004-04-16 2004-04-14 S Sale DAVIS C GEOFFREY

Chief Scientific Officer

Officer
31,760 -69.1%
13.33
US$423,297 		31,760 -69.1% 13.33 US$423,297
2004-02-09 2004-02-06 B Purchase WIGGANS THOMAS G
1,000 +inf%
15.21
US$15,205 		1,000 +inf% 15.21 US$15,205
2004-02-09 2004-02-06 PlS Planned sale DAVIS C GEOFFREY

Chief Scientific Officer
4,064 -22.3%
15.22
US$61,854 		4,064 -22.3% 15.22 US$61,854
Explore more

More insider trading research around Amgen Fremont Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America